Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07041944 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

HEMImprove 1.0 in Children and Adolescents With Unilateral Cerebral Palsy

Study acronym: HEMImprove-APP
StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Feb 1, 2026 to Feb 1, 2027
    • Start date: Sep 1, 2025 to Mar 1, 2026
    • Study completion date: Apr 1, 2026 to Dec 1, 2027
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study aims to evaluate the effectiveness and usability of HEMImprove 1.0, a gamified mobile application designed to improve upper limb motor function in adolescents with unilateral cerebral palsy. Participants will be randomly assigned to an intervention group using the app or a control group performing conventional home exercises. The intervention will last four weeks, with assessments before and after the intervention to measure motor function, motivation, and quality of life improvements.
Trial Details
NCT Number NCT07041944
Lead Sponsor University of Castilla-La Mancha
Conditions
(from sponsor)		 Unilateral Cerebral Palsy
Enrollment 36 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov